305 related articles for article (PubMed ID: 25862436)
1. Direct oral anticoagulants in the secondary prevention of stroke and transient ischemic attack in patients with atrial fibrillation.
Arnao V; Agnelli G; Paciaroni M
Intern Emerg Med; 2015 Aug; 10(5):555-60. PubMed ID: 25862436
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
Saxena R; Koudstaal P
Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
Aguilar MI; Hart R; Pearce LA
Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
[TBL] [Abstract][Full Text] [Related]
6. Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study.
Yoshimura S; Koga M; Sato S; Todo K; Yamagami H; Kumamoto M; Itabashi R; Terasaki T; Kimura K; Yagita Y; Shiokawa Y; Kamiyama K; Okuda S; Okada Y; Takizawa S; Hasegawa Y; Kameda T; Shibuya S; Nagakane Y; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Fujita K; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yamaguchi Y; Kinoshita N; Matsuki T; Takasugi J; Tokunaga K; Higashida K; Homma K; Kario K; Arihiro S; Toyoda K;
Circ J; 2018 Jun; 82(7):1935-1942. PubMed ID: 29863095
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
Koudstaal PJ
Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y;
J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691
[TBL] [Abstract][Full Text] [Related]
9. Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.
Tentschert S; Parigger S; Dorda V; Bittner K; Unterbuchschachner D; Greisenegger S; Wimmer R; Brücke T; Lang W; Lalouschek W;
Wien Klin Wochenschr; 2004 Dec; 116(24):834-8. PubMed ID: 15690967
[TBL] [Abstract][Full Text] [Related]
10. Comparison of primary and secondary stroke prevention in patients with nonvalvular atrial fibrillation: Results from the RAFFINE registry.
Yamashiro K; Tanaka R; Miyazaki S; Miyauchi K; Hayashi H; Nishizaki Y; Nojiri S; Suwa S; Sumiyosi M; Nakazato Y; Urabe T; Hattori N; Minamino T; Daida H
J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106871. PubMed ID: 36356431
[TBL] [Abstract][Full Text] [Related]
11. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
12. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
Koudstaal PJ
Cochrane Database Syst Rev; 2000; (2):CD000186. PubMed ID: 10796314
[TBL] [Abstract][Full Text] [Related]
14. Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation.
Oertel LB; Fogerty AE
J Am Assoc Nurse Pract; 2017 Sep; 29(9):551-561. PubMed ID: 28805310
[TBL] [Abstract][Full Text] [Related]
15. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
[TBL] [Abstract][Full Text] [Related]
16. WITHDRAWN: Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
Koudstaal PJ
Cochrane Database Syst Rev; 1996 Apr; (1):CD000186. PubMed ID: 17636615
[TBL] [Abstract][Full Text] [Related]
17. Early initiation of new oral anticoagulants in acute stroke and TIA patients with nonvalvular atrial fibrillation.
Shibazaki K; Kimura K; Aoki J; Saji N; Sakai K
J Neurol Sci; 2013 Aug; 331(1-2):90-3. PubMed ID: 23743245
[TBL] [Abstract][Full Text] [Related]
18. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
[TBL] [Abstract][Full Text] [Related]
19. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D
Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
